Edward Yull

About

ARCHIMED is a leading, global private equity firm focused exclusively on healthcare industries. Our international team combines investment, medical, scientific and operational expertise to serve as a strategic and financial partner to European and North American healthcare enterprises. Ultimately, ARCHIMED strives to build bigger and better healthcare businesses to deliver improved health outcomes and help people across the world.

Experience

• Board Observer at Arkstone
  Sep 2025 - Present · 10 mos

• ARCHIMED (4 yrs 10 mos)
  • Private Equity Associate
    Feb 2024 - Present · 2 yrs 5 mos

    Rotation to Tokyo office for 1 year.

  • Private Equity Analyst
    Sep 2021 - Feb 2024 · 2 yrs 6 mos

• Natus Medical Incorporated (3 yrs 2 mos)
  • Board Observer - Natus Neuro
    Apr 2024 - Sep 2025 · 1 yr 6 mos

  • Board Observer
    Aug 2022 - Apr 2024 · 1 yr 9 mos

• Board Observer at Title21 Health Solutions
  Jul 2022 - Sep 2024 · 2 yrs 3 mos

• Private Equity Junior Analyst at Novacap
  2021 - 2021 · Less than a year